RIGL Operating Cash Flow (Statement)

Rigel Pharmaceuticals Inc · Operating Cash Flow (Statement)

RIGL logo

RIGL Operating Cash Flow (Statement)

Latest reported$79.39M
RIGL Cash from Operations (-$7.83M → $79.39M)
High-resolution chart · PNG

RIGL operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
75,655,000
31,471,000
-5,743,000
-73,758,000
5,878,000
-52,185,000
-41,510,000
-58,826,000
-77,557,000
-75,889,000
-23,413,000
-69,753,000
-86,061,000
-85,192,000
-69,375,000
46,743,000
-102,779,000
-103,518,000
-52,207,000
-35,836,000
-35,170,000
-38,152,000
-32,440,000
-34,528,000
-15,981,000
-11,588,000
-7,831,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.